![]() |
|
|
Vol. 20, Issue 24, 5236-5249, December 15, 2009
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shedding



,||
*Department of Biochemistry and Biophysics and
Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC 27599;
Departments of Pediatrics and Cell Biology, Vanderbilt University, Nashville, TN 37232; and
Department of Biochemistry and Molecular Genetics, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime 791-0295, Japan
Submitted January 2, 2009;
Revised September 28, 2009;
Accepted October 14, 2009
Monitoring Editor: J. Silvio Gutkind
Epidermal growth factor receptor (EGFR) activation by GPCRs regulates many important biological processes. ADAM metalloprotease activity has been implicated as a key step in transactivation, yet the regulatory mechanisms are not fully understood. Here, we investigate the regulation of transforming growth factor-
(TGF-
) shedding by reactive oxygen species (ROS) through the ATP-dependent activation of the P2Y family of GPCRs. We report that ATP stimulates TGF-
proteolysis with concomitant EGFR activation and that this process requires TACE/ADAM17 activity in both murine fibroblasts and CHO cells. ATP-induced TGF-
shedding required calcium and was independent of Src family kinases and PKC and MAPK signaling. Moreover, ATP-induced TGF-
shedding was completely inhibited by scavengers of ROS, whereas calcium-stimulated shedding was partially inhibited by ROS scavenging. Hydrogen peroxide restored TGF-
shedding after calcium chelation. Importantly, we also found that ATP-induced shedding was independent of the cytoplasmic NADPH oxidase complex. Instead, mitochondrial ROS production increased in response to ATP and mitochondrial oxidative complex activity was required to activate TACE-dependent shedding. These results reveal an essential role for mitochondrial ROS in regulating GPCR-induced growth factor shedding.
||Present address: The Office of the Vice President for Research, University of Georgia, Athens, GA 30602.
Address correspondence to: Susan Wohler Sunnarborg (susan_sunnarborg{at}med.unc.edu).
Abbreviations used: ADAM, a disintegrin and metalloprotease; AR, amphiregulin; BIM-I, bisindolylmaleimide I; DPI, diphenyleneiodonium; EGF, epidermal growth factor; EGFR, epidermal growth factor receptor; GPCR, G-protein–coupled receptor; HB-EGF, heparin-binding growth factor; MAPK, mitogen-activated protein kinase; NAC, N-acetyl-L-cysteine; PKC, protein kinase C; PMA, phorbol 12-myristate 13-acetate; RIA, radioimmunoassay; ROS, reactive oxygen species; TACE, tumor necrosis factor-
–converting enzyme; TGF-
, transforming growth factor-
.